Life Technologies this week named Alan Sachs as head of global research and development and Ronnie Andrews as president of medical sciences.
Sachs was previously the vice president of exploratory and translational sciences for Merck Research Laboratories, where he spent 10 years in various leadership roles, Life Tech said. Prior to that Sachs served an associate professor of biochemistry and molecular biology at the University of California, Berkeley; and as a Whitehead fellow at the Whitehead Institute for Biomedical Research.
He holds a PhD in cell biology from Stanford University; an MD from the Stanford School of Medicine; and a BA in biochemistry from Cornell University.
Andrews joins Life Tech from GE Molecular Diagnostics, where he served as a segment leader following GE's 2010 acquisition of Clarient, where Andrews was CEO. Andrews has also held executive positions with Abbott Diagnostics, Roche Diagnostics, and Immucor. Andrews received a BS in biology and chemistry from Wofford College.
As president of medical sciences at Life Tech, Andrews will help expand Life's presence in the diagnostics and personalized medicine space through strategies including short- and long-term partnerships, the company said.
Roche said this week that it has named Dan Zabrowski as head of Roche Applied Science in the company's diagnostics division in Penzberg, Germany.
Zabrowski succeeds Paul Brown, who led Roche Applied Science since September 2011. Zabrowski will report to Daniel O'Day, COO of Roche Diagnostics.
Zabrowski most recently served as global head of Roche partnering and was a member of the Roche corporate executive committee and Chugai board. He joined Roche in 1994 through the acquisition of Syntex. During his career at Roche, Zabrowski held a number of management positions in regulatory affairs and development. He holds a PhD in organic chemistry from the University of Indiana.